• 左
  • 右

铼羰基化合物标记含RGD的多肽

马玉飞, 于俊峰, 周伟, 沈华, 胡伟青, 尹端沚

马玉飞, 于俊峰, 周伟, 沈华, 胡伟青, 尹端沚. 铼羰基化合物标记含RGD的多肽[J]. 核化学与放射化学, 2009, 31(1): 23-27.
引用本文: 马玉飞, 于俊峰, 周伟, 沈华, 胡伟青, 尹端沚. 铼羰基化合物标记含RGD的多肽[J]. 核化学与放射化学, 2009, 31(1): 23-27.
MA Yu-fei, YU Jun-feng, ZHOU Wei, SHEN Hua, HU Wei-qing, YIN Duan-zhi. Radiolabeling RGD-Peptide Using fac-[188Re(CO)3(H2O)3]+ [J]. Journal of Nuclear and Radiochemistry, 2009, 31(1): 23-27.
Citation: MA Yu-fei, YU Jun-feng, ZHOU Wei, SHEN Hua, HU Wei-qing, YIN Duan-zhi. Radiolabeling RGD-Peptide Using fac-[188Re(CO)3(H2O)3]+ [J]. Journal of Nuclear and Radiochemistry, 2009, 31(1): 23-27.

铼羰基化合物标记含RGD的多肽

详细信息
  • 中图分类号: R817

Radiolabeling RGD-Peptide Using fac-[188Re(CO)3(H2O)3]+

  • 摘要: αvβ3是一种在包括肿瘤引起的血管增生及肿瘤转移中起重要作用的细胞黏附受体,含RGD序列的肽及其类似物可以作为拮抗剂与αvβ3正常配体进行竞争结合。本工作以三羰基铼为前体标记了2个含有RGD序列的多肽,实验结果表明,2个多肽的标记率和放化纯度均大于90%,体外稳定性良好。将进一步对其进行生物评价,以判别其是否有潜力发展成为肿瘤治疗剂。
    Abstract: Integrin αvβ3 is a member of the integrin family, which plays an important role in angiogenesis and tumour metastasis. The peptides containing arginine-glycine-aspartic acid(RGD) sequence can bind to integrin αvβ3 selectively. In the present study, we labeled two RGD-peptides via fac-[188Re(CO)3(H2O)3+. The results show that the labeling yields are more than 90% for both of radiolabeled compounds, and they are all stable in phosphate buffered saline and new-born calf serum, even challenged in histidine or cysteine solution. We will evaluate their biological properties to develop radiolabeled agents for tumor therapy.
  • [1] Zhang Xianzhong, Chen Xiaoyuan. Preparation and Characterization of 99Tcm(CO)3-BPy-RGD Complex as αvβ3 Integrin Receptor-Targeted Imaging Agent[J]. Appl Radiat Isot, 2007, 65: 70-78.
    [2] 李前伟.肿瘤整合素αvβ3受体显像的研究现状[J].国外医学-放射医学核医学分册,2003, 27(5): 198.
    [3] Merdith J E, Fazeli B, Schwartz M A. The Extracellular Matrix as a Cell Survival Factor[J]. Mol Biol Cell, 1993, 4(9): 953-961.
    [4] Brakebusch C, Bouvard D, Stanchi F, et al. Integrins in Invasive Growth[J]. J Clin Invest, 2002, 109: 999-1 006.
    [5] Nicosia R F, Bonanno E. Inhibition of Angiogenesis in Vitro by RGD-Containing Synthetic Peptide [J]. Am J Pathol, 1991, 138: 829-833.
    [6] De S, Razorenova O, McCabe N P, et al. VEGF-Integrin Interplay Controls Tumor Growth and Vascularization[J]. Proc Natl Acad Sci U S A, 2005, 102: 7 589-7 594.
    [7] Robinson S D, Reynolds L E, Wyder L, et al. β3-Integrin Regulates Vascular Endothelial Growth Factor-A-Dependent Permeability[J]. Arterioscler Thromb Vasc Biol, 2004, 24: 2 108-2 114.
    [8] Friedlander M, Brooks P C, Shaffer R W, et al. Definition of Two Angiogenic Pathways by Distinct αv Integrins[J]. Science, 1995, 270: 1 500-1 502.
    [9] 张雷.整合素与肿瘤[J].重庆医学,2003, 32(9): 1 261.
    [10] Kim J W, Lee H S. Tumor Targeting by Doxorubicin-RGD-4C Peptide Conjugate in an Orthotopic Mouse Hepatoma Model [J]. Int J Mol Med, 2004, 14: 529-535.
    [11] Chen X Y, Liu S, Hou Y P, et al. MicroPET Imaging of Breast Cancer αv-Integrin Expression With 64Cu-Labeled Dimeric RGD Peptides [J]. Mol Imag Biol, 2004, 6(5): 356-359.
    [12] Chen X Y, Park R, Shahinian A H, et al. Pharmacokinetics and Tumor Retention of 125I-Labeled RGD Peptide are Improved by PEGylation [J]. Nucl Med Biol, 2004, 31: 11-19.
    [13] Haubner R, Brucheritseifer M, Bock M, et al. Synthesis and Biological Evaluation of a 99Tcm-Labelled Cyclic RGD Peptide for Imaging αvβ3 Expression[J]. Nuklearmedizin, 2004, 43: 26-32.
    [14] Psimadas D, Fani M, Zikos C, et al. Study of the Labeling of Two Novel RGD-Peptidic Derivatives With the Precursor [99Tcm(H2O)3(CO)3]+ and Evaluation for Early Angiogenesis Detection in Cancer [J]. Appl Radiat Isot, 2004, 31: 11-19.
    [15] 唐林,于俊峰,郑明强,等.铼[188Re]羰基化合物标记含RGD的环肽及其生物分布[J].核技术,2006, 29(6): 50-54.
    [16] Dijkgraaf I, Kruijtzer J A W, Frielink C, et al. αvβ3 Integrin-Targeting of Intraperitoneally Growing Tumours With a Radiolabeled RGD Peptide [J]. Int J Cancer, 2006, 120: 605-610.
    [17] Dijkgraaf I, Kruijtzer J A W, Liu S, et al. Improved Targeting of the αvβ3 Integrin by Multimerisation of RGD Peptides[J]. Eur J Nucl Med Mol Imag, 2007, 34: 267-273.
    [18] Zhang X L, Zhang C F, Li J L, et al. Progress on Studying 188Re Labeled Peptide[J]. Nul Tech, 2002, 25(7): 587-592.
    [19] Yu Junfeng, Hfeli Urs O, Xia Jiaoyun, et al. Radiolabelling of Poly(Histidine) Derivatized Biodegradable Microspheres With the 188Re Tricarbonyl Complex [188Re(CO)3(H2O)3]+ [J]. Nucl Med Comm, 2005, 26(5): 453-458.
    [20] Wester H J. Molecular Targeting With Peptides or Peptide-Polymer Conjugates: Just a Question of Size[J]. J Nucl Med, 2005, 46(12): 1 940-1 945.
计量
  • 文章访问数:  1617
  • HTML全文浏览量:  0
  • PDF下载量:  3249
  • 被引次数: 0
出版历程
  • 收稿日期:  2008-07-17
  • 修回日期:  2008-09-21
  • 刊出日期:  2009-02-19

目录

    /

    返回文章
    返回